Atlas Trials

A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients

Clinical trial NCT00046332 · COMPLETED

Trial details

NCT number
NCT00046332
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV Infections
Start date
2002-06-01
Primary completion
2003-01-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.